Cantor Fitzgerald projects a $200B valuation for Hyperliquid’s HYPE token, signaling Wall Street’s shift toward perp DEX ...

Cantor Fitzgerald analyst Matthew O’Keefe initiated coverage of Vizsla Silver (VZLA) with a Buy rating and $7 price target Published first on ...

Marvell Technology Inc. (NASDAQ:MRVL) is one of the best stocks to buy for the next 5 years. On December 16, Cantor ...

On December 16, Cantor Fitzgerald cut its price target on Advanced Micro Devices, Inc. (NASDAQ:AMD) to $300 from $350 while ...

Rival platforms pose a short-term risk to Hyperliquid, even as DEX adoption grows and Cantor Fitzgerald forecasts a HYPE rally to $200 by 2035.

Since most of the fees are used for token buyback, Cantor projected that Hyperliquid’s [HYPE] value could trade at a ...

Cantor Fitzgerald initiated coverage of ArriVent Biopharma (AVBP) with an Overweight rating. Firmonertinib is approved in China for first-line ...

Cantor Fitzgerald LP and two affiliate firms escaped claims they unlawfully enforced noncompete provisions in partnership ...

Cantor Fitzgerald projects that Hyperliquid’s HYPE token will surge 2,000% to hit $200 billion in market cap. The Wall Street ...

Senate Finance Committee ranking member Ron Wyden (D-Ore.) and Banking Committee ranking member Elizabeth Warren (D-Mass.) have warned Cantor Fitzgerald & Co., a finance firm linked to Commerce ...

Cantor Fitzgerald has expressed an optimistic outlook for financial markets in the near term, and into 2026. Learn more here.